Alphabet's DeepMind Unveils AlphaGenome 2 AI Model for DNA Analysis
DeepMind, the artificial intelligence subsidiary of Alphabet (GOOGL), has introduced AlphaGenome 2, a new generative AI model designed to analyze and interpret DNA at the cellular level. Unlike previous iterations that relied on broad tissue averages, this model allows researchers to zoom in on specific cell types and individual cell states. The development represents a significant advancement in computational biology, offering more granular insights into genomic data. By providing high-resolution readings of DNA cells, AlphaGenome 2 is positioned to accelerate biological research and potentially transform drug discovery processes through improved precision in understanding cellular mechanics.
Topics: Artificial Intelligence Biotechnology Genomics
Read the full article at Seeking Alpha
Part of the story Google DeepMind Unveils AlphaGenome 2 to Predict Cellular Effects of DNA Mutations (2 articles)